All Articles

After a period of explosive growth under Owner Resource Group, the tech-forward BPO provider begins a new chapter with Chicago-based private equity firm Frontenac.

FDA clears Allevion's Vantage™, a disposable kit with integrated visualization that targets bone growth, aiming to transform spinal decompression.

Sigma Nursing and Johnson & Johnson launch a new, free program to equip nurses with psychological tools for disaster response, aiming to combat burnout.

A global health leader is running for Congress in a crowded NYC primary, betting her scientific expertise can beat traditional politics.

Emerging player LunR Royalties finalizes a transformational silver stream on the Fruta Del Norte mine, a move poised to reshape its future and reward Lundin Gold's investors.

Crypto exchange Backpack appoints ex-Coinbase tech lead Nathan Smith as COO, signaling a major push for operational scale amid aggressive global expansion.

As PharmaCorp Rx prepares for a key investor conference, its strategy of consolidating independent pharmacies faces a pivotal test of market confidence.

Central 1 elects six new directors under a revamped governance model, reducing board size and shifting voting power in a move watched by the industry.

The materials tech firm gets a major vote of confidence from top banks, extending its financial runway to 2030 to fund growth and manage recent debt.

The junior explorer has applied to go public on the CSE, aiming to capitalize on soaring metal prices. But what are the risks and rewards for investors?

The lender hits its highest rank on Fortune's Best Companies list, but does a celebrated internal culture translate to success in a challenging economy?

As 'forever chemicals' plague South Florida, a new, costly plasma exchange therapy offers a solution. But is it a medical breakthrough or a luxury trend?

The final phase of the Tour & Taxis transformation begins, promising a sustainable district with 700+ homes, affordable housing, and geothermal energy.

With ex-Sierra Space CEO Tom Vice at the helm, Astrion signals a bold new era, aiming to disrupt the national security and space markets.

Amid a motorcoach market rebound, NFI Group separates MCI and names 30-year veteran Rob Marion as its new president to drive quality and growth.

A new grant from entrepreneur Andrew Hillman seeks global talent to solve biotech's biggest challenges. Who is the man behind this ambitious mission?

A new analysis finds 73% of B2B buyers use AI tools, which convert 5x better than Google. Yet, 78% of marketers have no strategy for this new reality.

President Trump's 100% tariff on imported drugs aims to secure the US supply chain, but the policy's success may hinge on unproven and unverified players.

After a years-long fight, a major airline caterer admits to violating worker rights, settling a key NLRB case and revealing a pattern of abuses.

With a veteran team and a focus on infill and ADUs, one San Diego firm aims to build attainable housing where it's needed most. Can they succeed?